Available IPD datapackage for study 'A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19'

Name: Available IPD datapackage for study 'A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19'
Creator: Vivli
Published: 2025-07-07 14:39:26
License: 暂无描述

DataCite Commons2025-07-07 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00008224.0

下载链接

链接失效反馈

官方服务：

资源简介：

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

提供机构：

Vivli

创建时间：

2025-07-07